Omeros(OMER),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OMER Omeros

Trading 07-02 14:41:18 EDT

9.14

-0.27

-2.87%

High9.62	Low9.00	Vol773.68K
Open9.41	D1 Closing9.41	Amplitude6.59%
Mkt Cap661.51M	Tradable Cap633.26M	Total Shares72.38M
T/O7.12M	T/O Rate1.12%	Tradable Shares69.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"OMER","market":"US","secType":"STK","nameCN":"Omeros","latestPrice":9.14,"timestamp":1783017668360,"preClose":9.41,"halted":0,"volume":773682,"delay":0,"changeRate":-0.028692879914984013,"floatShares":69284000,"shares":72375355,"eps":1.1905986,"marketStatus":"Trading","change":-0.27,"latestTime":"07-02 14:41:18 EDT","open":9.41,"high":9.62,"low":9,"amount":7119268.574964001,"amplitude":0.065887,"askPrice":9.14,"askSize":478,"bidPrice":9.12,"bidSize":191,"shortable":3,"etf":0,"ttmEps":1.1905986,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1783022400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1254974400000,"exchange":"NASDAQ","adjPreClose":9.41,"preHourTrading":{"tag":"盘前","latestPrice":9.42,"preClose":9.41,"latestTime":"09:14 EDT","volume":215,"amount":2006.6223049999999,"timestamp":1782998085059,"change":0.01,"changeRate":0.001063,"amplitude":0.031881},"postHourTrading":{"tag":"盘后","latestPrice":9.4831,"preClose":9.41,"latestTime":"19:49 EDT","volume":19574,"amount":184261.4558,"timestamp":1782949770646,"change":0.0731,"changeRate":0.007768,"amplitude":0.007768},"volumeRatio":0.265969,"impliedVol":0.94,"impliedVolPercentile":0.3665},"requestUrl":"/m/hq/s/OMER","defaultTab":"news","newsList":[{"id":"2646330369","title":"Omeros is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2646330369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646330369?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:39","pubTimestamp":1782488340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OMER/analyst-ratings(END) Dow Jones NewswiresJune 26, 2026 11:39 ET","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646695343","title":"Omeros price target lowered to $33 from $40 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2646695343","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646695343?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:30","pubTimestamp":1782487811,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Brandon Folkes lowered the firm’s price target on Omeros (OMER) to $33 from $40 and keeps a Buy rating on the shares after ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/omeros-price-target-lowered-to-33-from-40-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/omeros-price-target-lowered-to-33-from-40-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646364622","title":"FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide","url":"https://stock-news.laohu8.com/highlight/detail?id=2646364622","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646364622?lang=en_us&edition=fundamental","pubTime":"2026-06-26 23:16","pubTimestamp":1782486960,"startTime":"0","endTime":"0","summary":"EMA rejects Omeros' Yartemlea for TA-TMA, citing insufficient efficacy data, despite FDA approval and U.S. launch.","market":"us","thumbnail":"https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/06/26/3D-Rendering-Of-Human-Cells-In-A-Blue-Ba.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/cdn-cgi/image/width=260,format=auto,quality=85/files/images/story/2026/06/26/3D-Rendering-Of-Human-Cells-In-A-Blue-Ba.jpg"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/26/06/60130423/fda-approved-europe-unconvinced-omeros-stem-cell-transplant-treatment-hits-regulatory-divide","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/06/60130423/fda-approved-europe-unconvinced-omeros-stem-cell-transplant-treatment-hits-regulatory-divide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["LU0203347892.USD","BK4588","BK4170","BK4208","LU1003077747.HKD","SG9999001440.SGD","LU1894683264.USD","LU0661504455.SGD","CMS","LU2500361329.USD","LU0949170772.SGD","BK4007","LABU","LU0738911758.USD","LU0553294199.USD","LU2637428348.USD","LU1894683348.USD","LU2346227817.USD","LU0868494617.USD","BK4585","LU0203345920.USD","LU0868494708.USD","OMER","LU0942090050.USD","LU0545039389.USD","NTAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646350916","title":"Omeros Falls on Negative EU Opinion for Transplant Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2646350916","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646350916?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:09","pubTimestamp":1782479364,"startTime":"0","endTime":"0","summary":"BUZZ-Omeros falls on negative EU opinion for transplant drug** Biotech firm Omeros'OMER.Oshares fall 25.2% to $8.02 premarket** Company says European Medicines Agency's key panel issued a negative opinion on its application for its drug narsoplimab to treat transplant-associated thrombotic microangiopathy ** TA-TMA is a severe and often fatal complication that can occur after stem cell transplant in adults and children** OMER to request a re-examination of the opinion and review by an independent expert group**The drug, branded as Yartemlea in the United States, receivedapprovalby the U.S. FDA in December 2025 for TA-TMA patients aged two years and older** As of last close, OMER down 37.6% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4N42Y0U8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646357348","title":"Omeros Faces Negative EMA Panel Opinion on Narsoplimab Marketing Application for Ta-tma","url":"https://stock-news.laohu8.com/highlight/detail?id=2646357348","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646357348?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:30","pubTimestamp":1782477050,"startTime":"0","endTime":"0","summary":"Omeros faces negative EMA panel opinion on narsoplimab marketing application for TA-TMAOmeros faces a setback in Europe after the EMA’s CHMP adopted a negative opinion on its marketing application for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL3jnYPm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646573293","title":"Omeros Corp - Chmp Adopts Negative Opinion on Narsoplimab Maa for Ta-tma","url":"https://stock-news.laohu8.com/highlight/detail?id=2646573293","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646573293?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:30","pubTimestamp":1782477000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUA8SWQB9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646357389","title":"Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in Ta-tma","url":"https://stock-news.laohu8.com/highlight/detail?id=2646357389","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646357389?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:30","pubTimestamp":1782477000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUA8SWQB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646335732","title":"Omeros Corp - to Request Re-examination of Chmp Opinion and Review by Ad Hoc Expert Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2646335732","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646335732?lang=en_us&edition=fundamental","pubTime":"2026-06-26 20:30","pubTimestamp":1782477000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUA8SWQB9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646354891","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2646354891","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646354891?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:27","pubTimestamp":1782473269,"startTime":"0","endTime":"0","summary":"Lucas GC  shares were down 31% in Friday premarket activity, extending the previous session's 34% decline.Creative Medical Technology  stock was down 27%, a day after the company filed a preliminary prospectus for a securities offering.Focus Universal  shares were down 18%, following the previous session's 7.7% gain.Professional Diversity Network  stock was down 19% after the company filed a preliminary prospectus for a proposed offering of up to 15.7 million units and pre-funded warrants.Omeros  shares were down 16%, after a 1.3% gain in Thursday's session.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","BK4077","BK4130","FCUV","IPDN","BK4157","CELZ","LGCL","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646879216","title":"Omeros Shareholders Approve Executive Pay in Advisory Vote at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2646879216","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646879216?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:04","pubTimestamp":1782381842,"startTime":"0","endTime":"0","summary":"Omeros shareholders approve executive pay in advisory vote at annual meetingOmeros held its annual shareholder meeting on June 18, 2026.Shareholders backed an amended and restated omnibus incentive co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL4rGlG3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644088703","title":"Omeros agrees to repurchase up to $16 million of 9.5% convertible notes due 2029 for up to $34 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2644088703","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644088703?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:52","pubTimestamp":1781783579,"startTime":"0","endTime":"0","summary":"Omeros entered private deals to repurchase up to USD 16 million principal of its 9.50% Convertible Senior Notes due 2029.Total purchase price up to about USD 34 million, including accrued interest, subject to adjustment tied to the stock’s trading price.Repurchases are expected to close July 6-16; if completed in full, USD 54.8 million principal would remain outstanding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omeros Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL5xzDPf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205891","title":"Omeros announces annual shareholder meeting webcast details","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205891","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205891?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526641,"startTime":"0","endTime":"0","summary":"Omeros will hold its Annual Meeting of Shareholders in a virtual format on June 18, 2026.The meeting will include the formal business session, followed by a corporate overview and a Q&A segment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL1NM7GB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642537296","title":"Omeros trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2642537296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642537296?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:45","pubTimestamp":1781271942,"startTime":"0","endTime":"0","summary":"09:42 EDT Omeros (OMER) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try N...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/omeros-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/omeros-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642952862","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:40 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2642952862","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642952862?lang=en_us&edition=fundamental","pubTime":"2026-06-12 21:40","pubTimestamp":1781271617,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:40 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nAQN2M3A4K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642042340","title":"Omeros Price Target Maintained With a $40.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2642042340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642042340?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:44","pubTimestamp":1781091840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OMER/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 10, 2026 07:44 ET (11:44 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642440496","title":"H.C. Wainwright Keeps Their Buy Rating on Omeros (OMER)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642440496","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642440496?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:35","pubTimestamp":1781087733,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Omeros, with a price target of $40.00. According to TipR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-omeros-omer-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-omeros-omer-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638872634","title":"Omeros director Thomas J. Cable sells 7,500 shares worth $87,039‬","url":"https://stock-news.laohu8.com/highlight/detail?id=2638872634","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638872634?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:22","pubTimestamp":1779920527,"startTime":"0","endTime":"0","summary":"Omeros director Thomas J. Cable exercised stock options on May 22, 2026, acquiring 7,500 common shares at USD 10.84.Cable sold 7,500 common shares the same day at a weighted average USD 11.61.Directly held common shares fell to 35,067 following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omeros Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL2pJT36:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Omeros director Thomas J. Cable sells 7,500 shares worth $87,039‬","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638557269","title":"Aussie Broadband Updates Market on Director Michael Omeros’s Equity Interests","url":"https://stock-news.laohu8.com/highlight/detail?id=2638557269","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638557269?lang=en_us&edition=fundamental","pubTime":"2026-05-27 15:16","pubTimestamp":1779866216,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aussie Broadband Ltd. ( ($AU:ABB) ). Aussie Broadband has updated the market on a change in director Michael Om...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aussie-broadband-updates-market-on-director-michael-omeross-equity-interests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aussie-broadband-updates-market-on-director-michael-omeross-equity-interests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","OMER","BK4215","EQR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636383892","title":"Omeros Earnings Call: YARTEMLEA Fuels a New Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2636383892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636383892?lang=en_us&edition=fundamental","pubTime":"2026-05-20 11:03","pubTimestamp":1779246238,"startTime":"0","endTime":"0","summary":"Omeros Corporation (($OMER)) has held its Q1 earnings call. Read on for the main highlights of the call. Omeros Corporation’s latest earnings call ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/omeros-earnings-call-yartemlea-fuels-a-new-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/omeros-earnings-call-yartemlea-fuels-a-new-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635720484","title":"Omeros Earnings Call: YARTEMLEA Launch Drives New Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2635720484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635720484?lang=en_us&edition=fundamental","pubTime":"2026-05-15 08:38","pubTimestamp":1778805538,"startTime":"0","endTime":"0","summary":"Omeros Corporation (($OMER)) has held its Q1 earnings call. Read on for the main highlights of the call. Omeros Corporation’s latest earnings call ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/omeros-earnings-call-yartemlea-launch-drives-new-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/omeros-earnings-call-yartemlea-launch-drives-new-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.omeros.com","stockEarnings":[{"period":"1week","weight":-0.1106},{"period":"1month","weight":-0.1222},{"period":"3month","weight":-0.1367},{"period":"6month","weight":-0.4255},{"period":"1year","weight":2.1684},{"period":"ytd","weight":-0.4521}],"compareEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":-0.0168},{"period":"3month","weight":0.1371},{"period":"6month","weight":0.0916},{"period":"1year","weight":0.2074},{"period":"ytd","weight":0.0936}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's clinical programs include Narsoplimab (OMS721/MASP-2) that has completed pivotal studies for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that is in phase Ib clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders; and OMS405 that is in phase II clinical trials for opioid and nicotine addiction. In addition, the company develops MASP-2-small-molecule inhibitors for the treatment of aHUS, HSCT-TMA, and age-related macular degeneration; GPR174 inhibitors and chimeric antigen receptor T-Cell and adoptive T-Cell therapies for various cancers; and G protein-coupled receptors for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":-0.012739},{"month":2,"riseRate":0.588235,"avgChangeRate":0.056959},{"month":3,"riseRate":0.588235,"avgChangeRate":0.084424},{"month":4,"riseRate":0.411765,"avgChangeRate":-0.00729},{"month":5,"riseRate":0.352941,"avgChangeRate":-0.04488},{"month":6,"riseRate":0.294118,"avgChangeRate":0.025891},{"month":7,"riseRate":0.411765,"avgChangeRate":0.060988},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.029297},{"month":9,"riseRate":0.3125,"avgChangeRate":-0.001727},{"month":10,"riseRate":0.5,"avgChangeRate":-0.042054},{"month":11,"riseRate":0.647059,"avgChangeRate":0.236058},{"month":12,"riseRate":0.529412,"avgChangeRate":0.065706}],"exchange":"NASDAQ","name":"Omeros","nameEN":"Omeros"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Omeros(OMER),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Omeros(OMER) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Omeros,OMER,Omeros股票,Omeros股票老虎,Omeros股票老虎国际,Omeros行情,Omeros股票行情,Omeros股价,Omeros股市,Omeros股票价格,Omeros股票交易,Omeros股票购买,Omeros股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Omeros(OMER),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Omeros(OMER) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}